A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...
Barclays raised the firm’s price target on Progressive (PGR) to $264 from $261 and keeps an Equal Weight rating on the shares. Ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback